OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial

Background: Pediatric obesity is a chronic disease with rising prevalence and limited treatment options; first-line intervention is lifestyle therapy, which is typically unsuccessful.(1) Liraglutide (3.0 mg) as an adjunct to lifestyle therapy has provided weight loss and improved cardiometabolic ris...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Kelly, Aaron S, Auerbach, Pernille, Barrientos-Perez, Margarita, Gies, Inge, Hale, Paula M, Marcus, Claude, Mastrandrea, Lucy D, Prabhu, Nandana, Arslanian, Silva
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Adipose Tissue, Appetite, and Obesity
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208432/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.413
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars